Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), an
about
Fractal lacunarity of trabecular bone and magnetic resonance imaging: New perspectives for osteoporotic fracture risk assessmentMyopenia-a new universal term for muscle wastingSarcopenia with limited mobility: an international consensus.Bisphosphonate drug holidays: Can we recommend currently?Sex and gender considerations in male patients with osteoporosisMethods of formal consensus in classification/diagnostic criteria and guideline development.Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday.Correlation of hip fracture with other fracture types: Toward a rational composite hip fracture endpointCost-effectiveness of universal serologic screening to prevent nontraumatic hip and vertebral fractures in patients with celiac disease.Placebo-controlled trials in osteoporosis--proceeding with caution.Safety concerns with the long-term management of osteoporosis.Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins.Effect of monthly ibandronate on hip structural geometry in men with low bone density.Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.Can Change in FRAX Score Be Used to “Treat to Target”? A Population-Based Cohort Study
P2860
Q28081908-B6ABE11A-6F55-4425-8562-5ACD5DA59841Q28741675-570006B6-CF5E-4020-B96D-C1FC3F587AC6Q34189767-FEC0B21F-FA78-4125-8A42-B970ACE3FD89Q34329746-FCD43E07-DE03-4108-A02B-54663CFECF47Q35036493-EBCC4CDD-0825-4D82-9986-9402329DE391Q35091202-99C72543-F97C-4528-B258-FE47E33E5050Q36523054-4E038F19-3B5E-407A-891B-405E605EA593Q36635855-6BA2FC68-1E71-4B77-A6A7-BB8CCF5A0E18Q36847433-03BDB8B0-F219-4F64-8667-55BD9A01316FQ37513845-3934CC74-148F-4225-833C-C052EEABDBCBQ38101363-4D6E0872-C696-4FC5-9859-AD425DA57572Q43139937-F71F3968-C3C3-4785-96A4-68B167A704DDQ46047966-8BE5622C-113C-4D0F-A376-AA18EE864588Q47771776-50F7E61D-01D8-46D6-9ABF-E257017B9619Q57711187-9BD69ACA-4101-4338-B441-D1EB91D484FC
P2860
Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), an
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Recommendations for the clinic ...... inical Densitometry (ISCD), an
@en
type
label
Recommendations for the clinic ...... inical Densitometry (ISCD), an
@en
prefLabel
Recommendations for the clinic ...... inical Densitometry (ISCD), an
@en
P2093
P356
P1476
Recommendations for the clinic ...... inical Densitometry (ISCD), an
@en
P2093
Consensus Panel of the ASBMR, ISCD, and NOF
Nelson B Watts
Steven R Cummings
Stuart L Silverman
P304
P356
10.1359/JBMR.070905
P577
2008-01-01T00:00:00Z